Access Bio Inc (950130) — Capital Reinvestment Ratio
Access Bio Inc (950130) has a Capital Reinvestment Ratio of 0.12x as of March 2025, meaning it reinvests 0% of its operating cash flow (₩5.35 Million) in capital expenditures (₩635.11K). See how leveraged is Access Bio Inc's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Access Bio Inc Capital Reinvestment Ratio (2012–2024)
This chart tracks Access Bio Inc's Capital Reinvestment Ratio across 8 annual periods. Check Access Bio Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Access Bio Inc (2012–2024)
Year-by-year Capital Reinvestment Ratio for Access Bio Inc from 2012 to 2024. For live market cap and broader valuation context, see market cap of Access Bio Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | ₩13.54 Million | ₩1.40 Million | ▲ +101.5% |
| 2022 | 0.05x | ₩291.33 Million | ₩14.90 Million | ▼ -75.5% |
| 2021 | 0.21x | ₩137.90 Million | ₩28.76 Million | ▼ -26.3% |
| 2020 | 0.28x | ₩36.72 Billion | ₩10.38 Billion | ▼ -94.0% |
| 2016 | 4.74x | ₩2.11 Million | ₩10.03 Million | ▲ +180.1% |
| 2015 | 1.69x | ₩2.87 Billion | ₩4.85 Billion | ▲ +2.0% |
| 2013 | 1.66x | ₩1.59 Billion | ₩2.63 Billion | ▲ +134.3% |
| 2012 | 0.71x | ₩1.85 Billion | ₩1.31 Billion | — |